资讯

Sei Investments Co. lowered its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 10.8% in the fourth quarter, HoldingsChannel reports. The fund owned 133,578 shares of ...
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ® (pegvaliase-pqpz) met its primary efficacy endpoint, demonstrating a statistically ...